Convertible Debentures Wouldn't it be great if the company could/would issue convertable debentures as a means of raising cash for the upcoming clinical trials?
I think I would be interested in a 3 year debenture with any 8% annual coupon (payable at the end of three years) with the right to convert (anytime) the principal and interest into stock at say $0.65/share.
Available in $500 or $1,000 minimums the current shareholder base might be large enough to raise $5 million or more and any dilution that occurs would be an above market prices not below.